Premium
Glucocorticoids limit lipopolysaccharide‐induced lethal inflammation by a double control system
Author(s) -
Van Looveren Kelly,
Timmermans Steven,
Vanderhaeghen Tineke,
Wallaeys Charlotte,
Ballegeer Marlies,
Souffriau Jolien,
Eggermont Melanie,
Vandewalle Jolien,
Van Wyngene Lise,
De Bosscher Karolien,
Libert Claude
Publication year - 2020
Publication title -
embo reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.584
H-Index - 184
eISSN - 1469-3178
pISSN - 1469-221X
DOI - 10.15252/embr.201949762
Subject(s) - library science , medicine , computer science
Lipopolysaccharides ( LPS ) can lead to a lethal endotoxemia, which is a systemic inflammatory response syndrome ( SIRS ) characterized by a systemic release of cytokines, such as TNF . Endotoxemia is studied intensely, as a model system of Gram‐negative infections. LPS ‐ and TNF ‐induced SIRS involve a strong induction of interferon‐stimulated genes ( ISG s), some of which cause cell death in the intestinal epithelium cells ( IEC s). It is well known that glucocorticoids ( GC s) protect against endotoxemia. By applying numerous mutant mouse lines, our data support a model whereby GC s, via their glucocorticoid receptor ( GR ), apply two key mechanisms to control endotoxemia, (i) at the level of suppression of TNF production in a GR monomer‐dependent way in macrophages and (ii) at the level of inhibition of TNFR 1‐induced ISG gene expression and necroptotic cell death mediators in IEC s in a GR dimer‐dependent way. Our data add new important insights to the understanding of the role of TNF in endotoxemia and the two separate key roles of GC s in suppressing TNF production and activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom